Showing results (141-150 of 149) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Journal of Hepatology|January 28, 2021
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survivalDominik Bettinger, Lukas Sturm, Lena Pfaff, et al.Nature Communications|September 16, 2025
SARS-CoV-2 infection dynamics in a MHCI-mismatched lung transplant recipientJonas Fuchs, Vivien Karl, Ina Hettich, et al.The New England Journal of Medicine|September 3, 2024
Asundexian versus Apixaban in Patients with Atrial FibrillationJonathan P Piccini, Manesh R Patel, Jan Steffel, et al.Lancet (London, England)|September 5, 2022
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trialAshkan Shoamanesh, Hardi Mundl, Eric E Smith, et al.Journal of Virology|April 20, 2018
Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T CellsHadi Karimzadeh, Muthamia M Kiraithe, Anna D Kosinska, et al.Journal of Hepatology|April 3, 2022
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinomaMaryam Barsch, Henrike Salié, Alexandra Emilia Schlaak, et al.JHEP Reports : Innovation in Hepatology|April 7, 2023
Treating hepatitis D with bulevirtide - Real-world experience from 114 patientsChristopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.Journal of Hepatology|November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access programChristiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.The New England Journal of Medicine|April 15, 2026
Asundexian for Secondary Stroke PreventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.Pageof 15